Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-07-19FDA Approved: PHENOXYBENZAMINE HYDROCHLORIDE — Original Application (Novitium Pharma LLC)
FDA approved the original ANDA for phenoxybenzamine hydrochloride (generic) from Novitium Pharma LLC. The product is now available as a gene…
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for Jubilant Cadista's generic Losartan Potassium and Hydrochlorothiazide product.
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Teva's generic Losartan Potassium and Hydrochlorothiazide, expanding access to this antihype…
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Losartan Potassium by Camber Pharmaceuticals, enabling the marketing of a generic Losartan P…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension [Phase 2]
Phase 2 study assessing the dose of HCP1803 in patients with essential hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Activity Trackers for Improving BP [NA]
Completed clinical trial investigating activity trackers to improve blood pressure in hypertension and cardiovascular risk contexts; results…
-
FDA approval · 2022-07-13FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for a generic fixed-dose combination of losartan potassium and hydrochlorothiazide by NorthStar …
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Effect of Renal Denervation on Stress, Hypertension and Anxiety Management [Phase 2]
Phase 2 study evaluating the effect of renal denervation on stress, hypertension, and anxiety management.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Hemodynamic Changes During Operative Hysteroscopy [Phase 2]
Phase 2 clinical trial update assessing hemodynamic changes during operative hysteroscopy.
-
FDA approval · 2022-07-06FDA Approved: TRIAMTERENE — Original Application (Biocon Pharma Inc.)
The FDA approved Biocon Pharma Inc.'s original ANDA for Triamterene, granting generic approval to market Triamterene.
-
FDA approval · 2022-07-01FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, authorizing changes to the approved ANDA.
-
FDA approval · 2022-07-01FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for olmesartan medoxomil from Micro Labs Limited, granting approval of the generic product. This con…
-
FDA approval · 2022-07-01FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Olmesartan medoxomil from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project) [NA]
A completed clinical trial investigating reducing inequities in hypertension care and lifestyle improvement under the RICH LIFE Project.
-
FDA approval · 2022-06-30FDA Approved: RAMIPRIL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for ramipril submitted by Zydus Lifesciences Limited under ANDA078832.
-
FDA approval · 2022-06-29FDA Approved: ENALAPRIL MALEATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approves the original generic application for enalapril maleate (Enalapril) manufactured by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2022-06-28FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for olmesartan medoxomil filed by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2022-06-27FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for olmesartan medoxomil submitted by Alembic Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation [Phase 4]
Phase 4 clinical trial evaluating renal nerve stimulation in uncontrolled hypertension patients undergoing renal denervation is currently re…
-
FDA approval · 2022-06-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA approves a generic Verapamil Hydrochloride product from Lifestar Pharma LLC under an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2022-06-09Clinical Trial Update: A COmmunity and Tech-Based ApproaCh for Hypertension Self-MANagement [NA]
A completed clinical trial investigating a technology- and community-based self-management approach for hypertension.
-
FDA approval · 2022-06-08FDA Approved: GUANFACINE HYDROCHLORIDE — Original Application (TWi Pharmaceuticals, Inc.)
FDA approved guanfacine hydrochloride as an Original Application (ANDA) submission by TWi Pharmaceuticals, Inc., establishing a generic vers…
-
FDA approval · 2022-06-07FDA Approved: NADOLOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Nadolol submitted by Aurobindo Pharma Limited under the ANDA, approving updated labeling for…
-
FDA approval · 2022-06-01FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
The FDA approved a supplemental application for TOPROL XL (metoprolol succinate) submitted by Melinta Therapeutics, LLC. This action updates…